Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

Mashiningan improves opioid-induced constipation in rats by activating cystic fibrosis transmembrane conductance regulator chloride channel

Yumi Harada, Seiichi Iizuka, Yayoi Saegusa, Sachiko Mogami, Naoki Fujitsuka and Tomohisa Hattori
Journal of Pharmacology and Experimental Therapeutics May 2, 2017, jpet.117.240630; DOI: https://doi.org/10.1124/jpet.117.240630
Yumi Harada
Tsumura & Co.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seiichi Iizuka
Tsumura & Co.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yayoi Saegusa
Tsumura & Co.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sachiko Mogami
Tsumura & Co.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoki Fujitsuka
Tsumura & Co.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomohisa Hattori
Tsumura & Co.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

jpet.117.240630
DOI 
https://doi.org/10.1124/jpet.117.240630
PubMed 
28465373

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online May 2, 2017.

Article Versions

  • You are currently viewing an Earlier version of this article (May 2, 2017 - 12:09).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yumi Harada,
  2. Seiichi Iizuka,
  3. Yayoi Saegusa,
  4. Sachiko Mogami,
  5. Naoki Fujitsuka*, and
  6. Tomohisa Hattori
  1. Tsumura & Co.
  1. ↵*Address correspondence to: fujitsuka_naoki{at}mail.tsumura.co.jp

Statistics from Altmetric.com

Article usage

Article usage: May 2017 to January 2023

AbstractFullPdf
May 20171800100
Jun 20173727792
Jul 2017610332
Aug 201797732
Sep 20171529929
Oct 2017920722
Nov 201725226
Dec 201744721
Jan 201873210
Feb 201863120
Mar 2018174429
Apr 201823220
May 201843335
Jun 201833920
Jul 201883215
Aug 201823721
Sep 201855228
Oct 201884018
Nov 201826026
Dec 201815616
Jan 201914815
Feb 201944510
Mar 201953616
Apr 201918247
May 201942712
Jun 201921713
Jul 201913913
Aug 2019313520
Sep 201921469
Oct 20194397
Nov 201902717
Dec 201937818
Jan 202033816
Feb 202033014
Mar 202032412
Apr 20203298
May 202052114
Jun 20203206
Jul 202023422
Aug 202043117
Sep 202003016
Oct 202004615
Nov 202032714
Dec 202053213
Jan 202153319
Feb 202113112
Mar 202164328
Apr 202192814
May 202173018
Jun 202192315
Jul 2021131927
Aug 202178189
Sep 20213287
Oct 202132829
Nov 202123838
Dec 202145013
Jan 202243234
Feb 202234012
Mar 202223117
Apr 202233023
May 2022102716
Jun 20227387
Jul 20227196
Aug 202263316
Sep 202243429
Oct 202223317
Nov 202212410
Dec 202251913
Jan 20234164

Next
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 384 (2)
Journal of Pharmacology and Experimental Therapeutics
Vol. 384, Issue 2
1 Feb 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mashiningan improves opioid-induced constipation in rats by activating cystic fibrosis transmembrane conductance regulator chloride channel
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

Mashiningan improves opioid-induced constipation in rats by activating cystic fibrosis transmembrane conductance regulator chloride channel

Yumi Harada, Seiichi Iizuka, Yayoi Saegusa, Sachiko Mogami, Naoki Fujitsuka and Tomohisa Hattori
Journal of Pharmacology and Experimental Therapeutics May 2, 2017, jpet.117.240630; DOI: https://doi.org/10.1124/jpet.117.240630

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleGastrointestinal, Hepatic, Pulmonary, and Renal

Mashiningan improves opioid-induced constipation in rats by activating cystic fibrosis transmembrane conductance regulator chloride channel

Yumi Harada, Seiichi Iizuka, Yayoi Saegusa, Sachiko Mogami, Naoki Fujitsuka and Tomohisa Hattori
Journal of Pharmacology and Experimental Therapeutics May 2, 2017, jpet.117.240630; DOI: https://doi.org/10.1124/jpet.117.240630
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A Novel Long-Acting GLP-2, HM15912, for Short Bowel Syndrome
  • H2S Overproduction and Colonic Hypomotility in DM
  • MIP3a in Progressive Renal Injury Associated With Obesity
Show more Gastrointestinal, Hepatic, Pulmonary, and Renal

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics